Concepedia

Peng Wang

PW

Statistics

Publications

21

Citations

1.3K

H-Index

16

Active since

2015

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Discovery Institute

Sema4 (United States)

University of Pittsburgh

Peking University Third Hospital

Peng Wang is an author at Icahn School of Medicine at Mount Sinai specializing in life sciences, signal transduction, and pharmacology.

ORCID

Publications per year

2015–2024

21

Publications

21

A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication

Peng Wang, Juan Carlos Álvarez-Pérez, Dan P. Felsenfeld et al. · Nature Medicine · 2015 · 404 citations · Full text

, , +14

Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells

Peng Wang, Esra Karaköse, Hongtao Liu et al. · Cell Metabolism · 2018 · 161 citations · Full text

, , +9

Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas

Huan Wang, Aaron Bender, Peng Wang et al. · Nature Communications · 2017 · 88 citations · Full text

, , +17

Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation

Kunal Kumar, Peng Wang, Roberto Sánchez et al. · Journal of Medicinal Chemistry · 2018 · 78 citations · Full text

, , +15

Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human β-Cells

Hainan Chen, Jeffrey W. Kleinberger, Karen K. Takane et al. · Diabetes · 2015 · 59 citations · Full text

, , +17

1–5 of 21